Latest in: Milestone & Media Coverage

First Patient First Visit Achieved in Phase 2b RIV-CARE Trial of BV100

ADVANCE-ID is pleased to share a significant milestone in the Phase 2b RIV-CARE clinical trial, following BioVersys’ announcement on 29 October 2026 of the first patient first visit in the study. RIV-CARE is an open-label Phase …
October 29, 2026

ADVANCE-ID Celebrates Official Launch as WHO Collaborating Centre, featured in Singapore Media

ADVANCE-ID marked a significant milestone on 31 August 2026 with the official launch of its designation as a World Health Organization (WHO) Collaborating Centre for Clinical Trials, reinforcing its commitment to strengthening clinical research capacity and …
August 31, 2026
Logo-Lockup

Copyright © ADVANCE-ID. All rights reserved.

ADVANCE-ID
Saw Swee Hock School of Public Health
National University of Singapore

Tahir Foundation Building
National University of Singapore
12 Science Drive 2, #10-01, Singapore 117549
+65 6516 4988